English
SpanishTrusted Resources: Evidence & Education
Scientific literature and patient education texts
Medication for Graves’ Disease in Children
source: NYU Langone Hospitals
year: N/A
summary/abstract:Doctors at Hassenfeld Children’s Hospital at NYU Langone prescribe medications to treat children with Graves’ disease, an autoimmune disorder. That means the immune system attacks the thyroid and makes it produce too much thyroid hormone. Our doctors often recommend medication to decrease the production of these hormones and to diminish their effects on the body.
Doctors may prescribe an antithyroid medication called methimazole to slow the production of thyroid hormones. Methimazole is often effective in children who have mild symptoms of Graves’ disease. Your child takes this medication daily, by mouth.
Your child may begin to notice improvements in symptoms, such as reduced eye irritation, weight gain, and less sensitivity to temperature, after taking antithyroid medication for several weeks. Antithyroid therapy may be continued for several months, until the immune system reaction that triggered the condition subsides.
read more
myBinderRelated Content
-
Radioiodine Treatment for Thyroid DiseaseRadioiodine is a radioactive isotope of ...
-
The Natural History of Subclinical Hyperthyroidism in Graves’ Disease: The Rule of Thirds.Background: There is little information...
-
Thyroid-Associated Ophthalmopathy After Treatment for Graves’ Hyperthyroidism With Antithyroid Drugs or Iodine...Context: Previous randomized trials hav...
-
Remission of Graves’ Disease During Anti-Thyroid Drug Therapy: Time to Reconsider the Mechanism?Therapy of Graves' hyperthyroidism with ...
-
Radioactive Iodine Therapy vs. Antithyroid Medications for Graves’ DiseaseGraves disease is the most common cause ...
-
Comparative Analysis of Radioactive Iodine Versus Thyroidectomy for Definitive Treatment of Graves’ DiseaseBackground: Management of Graves diseas...
-
The Second Antithyroid Drug Treatment is Effective in Relapsed Graves’ Disease Patients: A Median 11-Year Foll...Background: Antithyroid drug (ATD) is a...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Brought to you by
Supported through an independent
educational grant by
